277 related articles for article (PubMed ID: 23211262)
21. How often do patients attend general practice, how often are they referred to hospital, and how do multi-morbidity and polypharmacy affect general practice attendance and referral rates?
O'Regan A; Glynn L; Niranjamn V; O'Connor R; Hannigan A
Rural Remote Health; 2023 Jan; 23(1):8106. PubMed ID: 36802742
[TBL] [Abstract][Full Text] [Related]
22. Effect of a patient-centered drug review on polypharmacy in primary care patients: study protocol for a cluster-randomized controlled trial.
Hasler S; Senn O; Rosemann T; Neuner-Jehle S
Trials; 2015 Aug; 16():380. PubMed ID: 26306691
[TBL] [Abstract][Full Text] [Related]
23. Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.
Menditto E; Gimeno Miguel A; Moreno Juste A; Poblador Plou B; Aza Pascual-Salcedo M; Orlando V; González Rubio F; Prados Torres A
PLoS One; 2019; 14(2):e0210701. PubMed ID: 30726245
[TBL] [Abstract][Full Text] [Related]
24. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for hospital admissions associated with adverse drug events.
Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
[TBL] [Abstract][Full Text] [Related]
26. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP Study.
Lozano-Hernández CM; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; Barrio-Cortes J; Gimeno-Feliu LA; Poblador-Plou B; Cura-González ID;
PLoS One; 2020; 15(6):e0235148. PubMed ID: 32579616
[TBL] [Abstract][Full Text] [Related]
27. Identifying Adverse Drug Events in Older Community-Dwelling Patients.
Cahir C; Wallace E; Cummins A; Teljeur C; Byrne C; Bennett K; Fahey T
Ann Fam Med; 2019 Mar; 17(2):133-140. PubMed ID: 30858256
[TBL] [Abstract][Full Text] [Related]
28. Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study.
Rogero-Blanco E; Del-Cura-González I; Aza-Pascual-Salcedo M; García de Blas González F; Terrón-Rodas C; Chimeno-Sánchez S; García-Domingo E; López-Rodríguez JA;
Eur J Gen Pract; 2021 Dec; 27(1):90-96. PubMed ID: 33982632
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
30. Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study.
Rogero-Blanco E; Lopez-Rodriguez JA; Sanz-Cuesta T; Aza-Pascual-Salcedo M; Bujalance-Zafra MJ; Cura-Gonzalez I;
JMIR Med Inform; 2020 Mar; 8(3):e14130. PubMed ID: 32149715
[TBL] [Abstract][Full Text] [Related]
31. Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-sectional Study.
Rogero-Blanco E; López-Rodríguez JA; Sanz-Cuesta T; Aza-Pascual-Salcedo M; Bujalance-Zafra MJ; Cura-González I;
JMIR Med Inform; 2020 Mar; 8(2):e14130. PubMed ID: 32126005
[TBL] [Abstract][Full Text] [Related]
32. Understanding the Extent of Polypharmacy and its Association With Health Service Utilization Among Persons With Cancer and Multimorbidity: A Population-Based Retrospective Cohort Study in Ontario, Canada.
Dean T; Koné A; Martin L; Armstrong J; Sirois C
J Pharm Pract; 2024 Feb; 37(1):35-46. PubMed ID: 35861340
[No Abstract] [Full Text] [Related]
33. Importance of healthcare utilization and multimorbidity level in choosing a primary care provider in Sweden.
Ranstad K; Midlöv P; Halling A
Scand J Prim Health Care; 2014 Jun; 32(2):99-105. PubMed ID: 24939741
[TBL] [Abstract][Full Text] [Related]
34. Adverse drug events in an intensive care unit of a university hospital.
Reis AM; Cassiani SH
Eur J Clin Pharmacol; 2011 Jun; 67(6):625-32. PubMed ID: 21246350
[TBL] [Abstract][Full Text] [Related]
35. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
[TBL] [Abstract][Full Text] [Related]
36. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population.
Aoki T; Yamamoto Y; Ikenoue T; Onishi Y; Fukuhara S
Sci Rep; 2018 Feb; 8(1):3806. PubMed ID: 29491441
[TBL] [Abstract][Full Text] [Related]
37. Fifteen-year trajectories of multimorbidity and polypharmacy in Dutch primary care-A longitudinal analysis of age and sex patterns.
Vos R; Boesten J; van den Akker M
PLoS One; 2022; 17(2):e0264343. PubMed ID: 35213615
[TBL] [Abstract][Full Text] [Related]
38. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
Jungo KT; Streit S; Lauffenburger JC
BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
[TBL] [Abstract][Full Text] [Related]
39. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.
Sevilla-Sanchez D; Molist-Brunet N; Amblàs-Novellas J; Roura-Poch P; Espaulella-Panicot J; Codina-Jané C
Eur J Clin Pharmacol; 2017 Jan; 73(1):79-89. PubMed ID: 27704168
[TBL] [Abstract][Full Text] [Related]
40. Current and future perspectives on the management of polypharmacy.
Molokhia M; Majeed A
BMC Fam Pract; 2017 Jun; 18(1):70. PubMed ID: 28587644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
